We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PEG:NYSEPublic Service Enterprise Group Incorporated Analysis

Data as of 2026-05-25 - not real-time

$79.51

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

PEG trades at $79.51, well below its DCF‑derived fair value of $94.23, implying roughly a 13% upside. The stock sits beneath its 20‑day ($78.73), 50‑day ($80.42) and 200‑day ($81.69) moving averages, and the 30‑day RSI of 52 indicates neutral momentum, while a bullish MACD histogram (+0.19) suggests a potential short‑term rebound toward the $82.16 resistance level. Volume is on an increasing trend, providing liquidity support as the price hovers just above the $76.05 support zone.
Fundamentally, PEG posted 19.4% revenue growth, a solid 17.6% profit margin and a PE of 17.6 versus the industry average of 22.0, reinforcing its undervalued status. The 3.37% dividend yield coupled with a 56.6% payout ratio appears sustainable given positive operating cash flow, and the company’s ultra‑low beta (0.29) and regulated utility profile keep overall risk low. Recent earnings beat and reaffirmed 2026 outlook add momentum, supporting a buy recommendation for medium‑ and long‑term horizons while a hold stance is prudent in the near term.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Recent earnings beat and positive outlook
  • Bullish MACD histogram despite bearish price trend
  • Increasing volume providing short‑term support

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value indicates ~13% upside
  • Revenue growth of 19.4% and profit margin above 17%
  • Attractive 3.37% dividend yield with sustainable payout

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Regulated utility business offering stable cash flows
  • Low beta (0.29) and low sector volatility
  • Undervalued valuation metrics relative to peers

Key Metrics & Analysis

Financial Health

Revenue Growth19.40%
Profit Margin17.69%
P/E Ratio17.6
ROE13.44%
ROA3.66%
Debt/Equity141.01
P/B Ratio2.3
Op. Cash Flow$3.5B
Free Cash Flow$-171750000
Industry P/E22.0

Technical Analysis

TrendBearish
RSI52.0
Support$76.05
Resistance$82.16
MA 20$78.73
MA 50$80.42
MA 200$81.69
MACDBullish
VolumeIncreasing
Fear & Greed Index91.7

Valuation

Fair Value$94.23
Target Price$89.75
Upside/Downside12.88%
GradeUndervalued
TypeBlend
Dividend Yield3.37%

Risk Assessment

Beta0.29
Volatility21.52%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.